Acorah Software Products - Accounts Production 16.8.310 false true false true No description of principal activity 1 December 2024 30 November 2025 30 November 2025 14469404 Dr Gareth Parry iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14469404 2024-11-30 14469404 2025-11-30 14469404 2024-12-01 2025-11-30 14469404 frs-core:CurrentFinancialInstruments 2025-11-30 14469404 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 14469404 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 14469404 frs-bus:Micro-entities 2024-12-01 2025-11-30 14469404 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 14469404 frs-bus:Director1 2024-12-01 2025-11-30
Registered number: 14469404
Dr John Gareth Parry Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2025
Elleri Accounting Solutions
Dr John Gareth Parry Ltd
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 14469404

| 2025
--- | ---
|  | £
Current assets |  | 38,471
Creditors: Amounts Falling Due Within One Year |  | (12,502 )
NET CURRENT ASSETS |  | 25,969
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 25,969
Accruals and deferred income |  | (740 )
NET ASSETS |  | 25,229
CAPITAL AND RESERVES |  | 25,229

## Notes

1. General Information
Dr John Gareth Parry Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14469404 . The registered office is Anaesthetic Department, Princess Of Wales Hospital, Bridgend, CF31 1RQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Gareth Parry Director
12/02/2026